Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aim Immunotech Inc 2117 SW HIGHWAY 484 OCALA FL 34473 USA

www.aimimmuno.com P: 352-448-7797

Description:

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.

Key Statistics

Overview:

Market Capitalization, $K 21,170
Enterprise Value, $K 16,420
Shares Outstanding, K 51,496
Annual Sales, $ 200 K
Annual Net Income, $ -28,960 K
Last Quarter Sales, $ 40 K
Last Quarter Net Income, $ -5,820 K
EBIT, $ -33,350 K
EBITDA, $ -33,100 K
60-Month Beta -0.36
% of Insider Shareholders 0.02%
% of Institutional Shareholders 12.02%
Float, K 51,486
% Float 99.98%
Short Volume Ratio 0.71

Growth:

1-Year Return -3.17%
3-Year Return -80.52%
5-Year Return -90.12%
5-Year Revenue Growth -45.95%
5-Year Earnings Growth 93.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 05/16/24
Next Earnings Date N/A
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr 53.85%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Yield 0.00%
Dividend Payable Date 12/31/14
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/29/16

AIM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -191.38%
Return-on-Assets % -128.26%
Profit Margin % -14,480.00%
Debt/Equity 0.20
Price/Sales 97.59
Price/Cash Flow N/A
Price/Book 4.70
Book Value/Share 0.10
Interest Coverage -0.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar